Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Saturn V Capital Management LP (CIK 1964437) reported $552.2M across 21 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ALMS ($70.5M, 12.77%), AMLX ($60.5M, 10.95%), ABVX ($60.4M, 10.94%), PCVX ($47.9M, 8.68%), PHVS ($33.9M, 6.15%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ALMS | ALUMIS INC | $70.5M | 12.77% | 3.2M | Added |
| 2 | AMLX | AMYLYX PHARMACEUTICALS INC | $60.5M | 10.95% | 4.3M | Trimmed |
| 3 | ABVX | ABIVAX SA | $60.4M | 10.94% | 542,696 | Trimmed |
| 4 | PCVX | VAXCYTE INC | $47.9M | 8.68% | 824,532 | Added |
| 5 | PHVS | PHARVARIS N V | $33.9M | 6.15% | 1.2M | Added |
| 6 | IMMX | IMMIX BIOPHARMA INC | $33.6M | 6.09% | 3.7M | Added |
| 7 | CELC | CELCUITY INC | $32.2M | 5.83% | 281,904 | Trimmed |
| 8 | JAZZ | JAZZ PHARMACEUTICALS PLC | $30.8M | 5.58% | 162,961 | Trimmed |
| 9 | IRON | DISC MEDICINE INC | $28.8M | 5.21% | 449,926 | Added |
| 10 | XFOR | X4 PHARMACEUTICALS INC | $26.7M | 4.83% | 6.5M | Added |
| 11 | COGT | COGENT BIOSCIENCES INC | $24.1M | 4.37% | 626,635 | Trimmed |
| 12 | MNPR | MONOPAR THERAPEUTICS INC | $18.9M | 3.43% | 345,626 | Added |
| 13 | DYN | DYNE THERAPEUTICS INC | $17.5M | 3.17% | 966,609 | Trimmed |
| 14 | IVVD | INVIVYD INC | $14.2M | 2.58% | 10.9M | Added |
| 15 | CADL | CANDEL THERAPEUTICS INC | $14.2M | 2.57% | 2.9M | New |
| 16 | OCS | OCULIS HOLDING AG | $13.7M | 2.49% | 516,761 | Hold |
| 17 | OVID | OVID THERAPEUTICS INC | $9.2M | 1.68% | 4.2M | Added |
| 18 | IKT | INHIBIKASE THERAPEUTICS INC | $6.5M | 1.18% | 3.9M | Added |
| 19 | ZURA | ZURA BIO LTD | $4.4M | 0.80% | 739,960 | New |
| 20 | ANRO | ALTO NEUROSCIENCE INC | $2.0M | 0.36% | 88,999 | New |
| 21 | MSCLF | SATELLOS BIOSCIENCE INC | $2.0M | 0.36% | 350,000 | New |
| 22 | CNTA | CENTESSA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | Exited |
| 23 | IVA | INVENTIVA SA | $0 | 0.00% | 0 | Exited |
| 24 | OCUL | OCULAR THERAPEUTIX INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31